Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Segarra

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Anales Espanoles De Pediatria|June 1, 1984
[Gastric duplication. Presentation of 4 cases localized in the antropyloric region]V Segarra Llido, A Gómez Fraile, C García-Sala Viguer, et al.
Journal of Medicinal Chemistry|February 26, 2000
Benzyl derivatives of 2,1,3-benzo- and benzothieno[3,2-a]thiadiazine 2,2-dioxides: first phosphodiesterase 7 inhibitorsA Martínez, A Castro, C Gil, et al.
Pulmonary Pharmacology & Therapeutics|August 15, 2015
Combined anti CXC receptors 1 and 2 therapy is a promising anti-inflammatory treatment for respiratory diseases by reducing neutrophil migration and activationA Planagumà, T Domènech, M Pont, et al.
Journal of Medicinal Chemistry|January 29, 2000
Synthesis and biological evaluation of 3,4-diaryloxazolones: A new class of orally active cyclooxygenase-2 inhibitorsC Puig, M I Crespo, N Godessart, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Anales Espanoles De Pediatria|June 1, 1984
[Gastric duplication. Presentation of 4 cases localized in the antropyloric region]V Segarra Llido, A Gómez Fraile, C García-Sala Viguer, et al.
Journal of Medicinal Chemistry|February 26, 2000
Benzyl derivatives of 2,1,3-benzo- and benzothieno[3,2-a]thiadiazine 2,2-dioxides: first phosphodiesterase 7 inhibitorsA Martínez, A Castro, C Gil, et al.
Pulmonary Pharmacology & Therapeutics|August 15, 2015
Combined anti CXC receptors 1 and 2 therapy is a promising anti-inflammatory treatment for respiratory diseases by reducing neutrophil migration and activationA Planagumà, T Domènech, M Pont, et al.
Journal of Medicinal Chemistry|January 29, 2000
Synthesis and biological evaluation of 3,4-diaryloxazolones: A new class of orally active cyclooxygenase-2 inhibitorsC Puig, M I Crespo, N Godessart, et al.
Pageof 4